Boston Scientific Corporation
Boston Scientific Corporation (BSX) Revenue
Annual & quarterly revenue history · segment & region breakdown
BSX · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBoston Scientific Corporation trailing twelve-month (TTM) revenue is $20.61B, an increase of 19.87% year-over-year from $20.07B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $20.07B | +$3.33B | +19.87% |
| 2024-12-31 | $16.75B | +$2.51B | +17.61% |
| 2023-12-31 | $14.24B | +$1.56B | +12.29% |
| 2022-12-31 | $12.68B | +$0.79B | +6.68% |
| 2021-12-31 | $11.89B | +$1.98B | +19.92% |
| 2020-12-31 | $9.91B | -$0.82B | -7.66% |
| 2019-12-31 | $10.73B | +$0.91B | +9.28% |
| 2018-12-31 | $9.82B | +$0.78B | +8.57% |
| 2017-12-31 | $9.05B | +$0.66B | +7.89% |
| 2016-12-31 | $8.39B | +$0.91B | +12.16% |
Compare revenue vs peers
Medical - DevicesCompare BSX revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Boston Scientific Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Boston Scientific Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Boston Scientific Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BSX revenue · 4 questionsBSX's trailing twelve-month (TTM) revenue is $20.61B. That is an increase of 19.87% year-over-year from $20.07B in FY2025.
▸ Source: FMP · Boston Scientific Corporation SEC filings · GAAP · Boston Scientific Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026